Brind.

Cystic Fibrosis Foundation provided $39 million in funding, while tariffs and onshoring benefit certain AI stocks.

1 report, 1 independent Updated Jul 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Cystic Fibrosis Foundation provided $39 million in funding, while tariffs and onshoring benefit certain AI stocks.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Insider MonkeyBMO Capital Maintains a Buy on Prime Medicine (PRME), Sets a $10 PT Prime Medicine Inc. (NASDAQ:PRME) is one of the hot penny stocks to invest in now. On July 16, BMO Capital analyst Kostas Biliouris